EU Medical AI Withdrawal Sparks Access Debate

The withdrawal of a medical artificial intelligence system from the European Union raises a fundamental question: who is allowed to use medical AI? Access to scientific evidence should not depend on where doctors are located, according to a guest commentary in the NZZ. The commentary argues that the pullback of the medical AI tool from the EU market highlights a broader issue about the availability of advanced medical technology across borders. It contends that physicians' access to evidence-based AI tools should not be restricted by their geographic location.